Rules and Regulations

Latest Issue of OR Manager
January 2025
Home Regulations/Legal > Rules and Regulations

Proposed tariffs, stricter immigration policies threaten healthcare workforce, supply chain

Editor's Note Immigration and trade policies proposed by President-elect Donald Trump could exacerbate challenges with healthcare staff and medical supply chains, according to recent reporting from Modern Healthcare and The Hill. As detailed by Modern Healthcare, stricter immigration policies could impede efforts to recruit skilled international workers, exacerbating gaps in…

Read More

By: Matt Danford
January 2, 2025
Share

Mastering CMS regulations: How to ensure a finding-free Joint Commission survey

Takeaways • Requirements for improvement and condition level deficiency findings have been trending up in recent The Joint Commission surveys. • The scoring trends and OR hot spots focus on infection control, medication management, national patient safety goals, post-surgical electronic health record tracers, and transplant (tissue) safety. • Federal regulations,…

Read More

By: Uyen Vo, BSN, MBA
January 1, 2025
Share

Surgical legislation advocacy focuses on safety, access

Carrie Zlatos, chief of legislative and political affairs at the American College of Surgeons (ACS), says: “Surgeons are the only people trained to provide surgery—life-saving care. They are an essential element of a community-based healthcare system. Regardless of where you live, everyone should have access to full quality surgical care.”…

Read More

By: Brita Belli
January 1, 2025
Share

FDA designates Class 1 recalls for balloon catheters, radiographic markers

Editor's Note Balloon catheters for atrial fibrillation patients and implantable radiographic markers were the subjects of separate US Food and Drug Administration (FDA) Class 1 recalls—the most severe category indicating risk of serious injury or death—announced on December 18. The first recall involves Boston Scientific’s POLARx Cryoablation devices. Higher-than-anticipated reports…

Read More

By: Matt Danford
December 19, 2024
Share

Sponsored Message

Antitrust guideline withdrawal could dampen M&A, boost uncertainty for provider joint ventures

Editor's Note In a move that could hinder provider-led joint ventures and increase regulatory uncertainty, the Federal Trade Commission (FTC) and the Justice Department have withdrawn antitrust guidance issued in 2000. Modern Healthcare reported the news on December 16. Passed in a 3-2 vote, the decision eliminates previously relied-upon safe…

Read More

By: Matt Danford
December 18, 2024
Share

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

Sponsored Message

Analysis: Guidance from leading medical journals mixed on AI use

JAMA (healthcare publication) Network logo

Editor's Note Leading medical journals vary significantly in guidance addressing the use artificial intelligence (AI) in medical research, according to an analysis published December 3 in JAMA Network Open.   The study categorized journals’ attitudes toward AI-assisted peer review into three groups: prohibition, limited use with conditions, and lack of explicit…

Read More

By: Matt Danford
December 10, 2024
Share

Advanced practice providers fill capacity gaps amid continued scope-of-practice debates

Editor's Note A recent report in Becker’s Hospital Review illuminated health systems’ efforts to address physician shortage by integrating advanced practice providers (APPs) into care models. Citing projections from the Bureau of Labor Statistics (BLS), Becker’s noted that nurse practitioners (NPs) “are the fastest-growing occupation in the country, with employment in…

Read More

By: Matt Danford
December 6, 2024
Share

FDA designates Class 1 recall for insulin syringes

Editor's Note The US Food and Drug Administration (FDA) designated Cardinal health’s recall of certain lots of the Monoject U-100 1 mL Syringe Luer-Lock with Tip Cap Soft Pack a Class 1, the most severe recall category indicating serious risk of injury or death. The product is designed to administer…

Read More

By: Matt Danford
December 5, 2024
Share

Study: Masking policies significantly reduce hospital-acquired viral respiratory infections

JAMA (healthcare publication) Network logo

Editor's Note A cohort study conducted across 10 hospitals in the Mass General Brigham system found that stopping universal masking and SARS-CoV-2 testing significantly increased hospital-onset respiratory viral infections, while reinstating masking for healthcare workers reduced those rates. As detailed in a November 27 research letter in Jama Network Open,…

Read More

By: Matt Danford
December 5, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat